RTI Surgical

Improving peoples’ quality of life by providing biologic implants used in a variety of critical surgical procedures

Group 3
Healthcare
Germany, USA
2020
Current
4000+

Donors received annually

c.590

Employees

8m+

Implants in patients

Leading designer, private label manufacturer and distributor of biologic implants (allografts and xenografts) used in a variety of critical surgical procedures.

A Montagu business

  • Must-have products used in surgical procedures
  • Highly differentiated capabilities including design and regulatory expertise, proprietary sterilisation processes and an extensive manufacturing footprint
  • Fundamentally attractive and resilient end-markets, underpinned by long-term trends including demographic growth, increasing prevalence of surgeries and the development of regenerative medicine
  • Substantial opportunity for growth through a value creation plan

Accelerating growth as an independent company

We are supporting management to:

  • Continue supporting surgical OEMs in their outsourcing journey and expand into new markets
  • Accelerate investments in product innovation, commercial proximity, and customer service
  • Invest in processes and systems to improve the organisation’s agility
  • Pursue selective strategic M&A to expand services, technical capabilities and geographical presence

Hear more from RTI Surgical on their cultural transformation: